AstraZeneca Reports Third-Quarter Revenue and Profit Growth
AstraZeneca said third-quarter revenue and profit increased, with strong cancer-drug sales offsetting the effect of patent expirations.
By Adria CalatayudAstraZeneca reported increases in revenue and profit for the third quarter, after strong sales of cancer drugs offset the effect of patent expirations to lift the group's top line.The U.K. drugmaker said Friday that it made a net profit of $3.12 billion for the third quarter, up f…